ponstel- mefenamic acid capsule
shionogi inc. - mefenamic acid (unii: 367589pj2c) (mefenamic acid - unii:367589pj2c) - mefenamic acid 250 mg - carefully consider the potential benefits and risks of ponstel and other treatment options before deciding to use ponstel. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings; gastrointestinal bleeding, ulceration, and perforation ). ponstel is indicated: - for relief of mild to moderate pain in patients ≥ 14 years of age, when therapy will not exceed one week (7 days). - for treatment of primary dysmenorrhea. ponstel is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to mefenamic acid or any components of the drug product (see warnings; anaphylactic reactions, serious skin reactions) . - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients (see warnings; anaphylactic reaction, exacerbation of asthma related to aspirin sensit
mefenamic acid 250mg capsules
a a h pharmaceuticals ltd - mefenamic acid - oral capsule - 250mg
mefenamic acid 250mg capsules
viatris uk healthcare ltd - mefenamic acid - oral capsule - 250mg
mefenamic acid 250mg capsules
kent pharma (uk) ltd - mefenamic acid - oral capsule - 250mg
mefenamic acid 250mg capsules
zentiva pharma uk ltd - mefenamic acid - oral capsule - 250mg
mefenamic acid 250mg capsules
alliance healthcare (distribution) ltd - mefenamic acid - oral capsule - 250mg
mefenamic acid 250mg capsules
arrow generics ltd - mefenamic acid - oral capsule - 250mg
mefenamic acid 250mg capsules
essential generics ltd - mefenamic acid - oral capsule - 250mg
mefenamic acid 250mg capsules
phoenix healthcare distribution ltd - mefenamic acid - oral capsule - 250mg
mefenamic acid 250mg capsules
advanz pharma - mefenamic acid - oral capsule - 250mg